Comparative Safety of JAK versus TNF Inhibitors in Older Adults with Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study.
OBJECTIVE This study evaluated the comparative safety of Janus kinase inhibitors (JAKi) vs tumor necrosis factor inhibitors (TNFi) among older adults aged ≥65 years with rheumatoid arthritis (RA), including a prespecified subgroup of patients aged ≥75 years. METHODS A retrospective cohort study was conducted using th...